Kristina Opletalová, MD; Xavier Blaizot, PhD; Bénédicte Mourgeon, RN; et al.
free access
Arch Dermatol. 2012;148(4):432-438. doi:10.1001/archdermatol.2011.1895
To study the efficacy of bagged larvae on wound debridement compared with conventional treatment, Opletalová and coauthors conducted a randomized, multicenter, controlled, prospective phase 3 trial with blinded assessment of outcome measures by a single observer in a random sample of 119 patients.
Pranita V. Rambhatla, MD; Henry W. Lim, MD; Iltefat Hamzavi, MD
free access
Arch Dermatol. 2012;148(4):439-446. doi:10.1001/archdermatol.2011.1950
Rambhatla et al performed a comprehensive review of research studies on Hidradenitis suppurativa (HS) treatment.
ONLINE FIRST
Rachel E. Sahn, MD; Mary Jayne McIlwain, MD; Kristin H. Magee, MD; et al.
free access
Arch Dermatol. 2012;148(4):448-454. doi:10.1001/archdermatol.2011.2072
The effect of sunless tanning products on tanning behaviors and the characteristics of sunless tanning product users was investigated by Sahn et al.
ONLINE FIRST
Samuel J. Balin, PhD; David A. Wetter, MD; Louise K. Andersen, MD; et al.
free access
Arch Dermatol. 2012;148(4):455-462. doi:10.1001/archdermatol.2011.2052
Balin et al describe the chacteristics and treatment of patients with calcinosis cutis in the clinical setting of autoimmune connective tissue disease (ACTD).
Ignacio Garcia-Doval, MScEpid, PhD; Gregorio Carretero, PhD; Francisco Vanaclocha, PhD; et al.
free access
Arch Dermatol. 2012;148(4):463-470. doi:10.1001/archdermatol.2011.2768
Garcia-Doval and coauthors used data from the BIOBADADERM Registry, which includes information from 13 dermatology departments in Spain, to report on the risk of serious adverse events in patients underrepresented in randomized controlled trials on systemic therapy for psoriasis.
Kate V. Viola, MD, MHS; Mamta B. Jhaveri, MD, MS; Pamela R. Soulos, MPH; et al.
free access
Arch Dermatol. 2012;148(4):473-477. doi:10.1001/archdermatol.2011.2456
Viola et al examine use rates of Mohs micrographic surgery and surgical excision for the treatment of nonmelanoma skin cancers among Medicare beneficiaries.
Camille Francès, MD; Anne Cosnes, MD; Pierre Duhaut, MD, PhD; et al.
free access
Arch Dermatol. 2012;148(4):479-484. doi:10.1001/archdermatol.2011.2558
In a prospective multicenter study, Francès and coauthors studied the relation between blood hydroxychloroquine levels and treatment outcomes in a series of patients with cutaneous lupus erythematosus (CLE).
Joel M. Gelfand, MD, MSCE; Joy Wan, BA; Kristina Callis Duffin, MD; et al.
free access
Arch Dermatol. 2012;148(4):487-494. doi:10.1001/archdermatol.2012.370
Gelfand and coauthors used a cross-sectional study design to compare biologic and nonbiologic systemic therapy with phototherapy in the treatment of psoriasis.
Khaled Ezzedine, MD, PhD; Abou Diallo, MD; Christine Léauté-Labrèze, MD; et al.
free access
Arch Dermatol. 2012;148(4):497-502. doi:10.1001/archdermatol.2011.351
Factors associated with halo nevi with nonsegmental vitiligo (NSV) vs NSV alone were compared by Ezzedine et al.